Impact of COVID-19 infection in patients with alpha-1 antitrypsin deficiency
The effect of α1-antitrypsin deficiency combined with increased bacterial loads on chronic obstructive pulmonary disease pharmacotherapy: A prospective, parallel, controlled pilot study - ScienceDirect
Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Defi | TCRM
State of the Evidence for AAT Therapy in AATD | Journal of The COPD Foundation
Global Alpha-1 Antitrypsin Drugs Market 2018-2022| Rising Patient Assistance Programs to Spur Growth| Technavio | BioSpace
Testing for α 1 -antitrypsin deficiency (AATD) and the estimated number... | Download Table
Surgery for patients with Alpha 1 Antitrypsin Deficiency: A review - ScienceDirect
What is A1ATD? | Asthma + Lung UK
Alpha1-antitrypsin deficiency, cirrhosis and emphysema | Thorax
The Pathophysiology of Antitrypsin Deficiency | Journal of The COPD Foundation
A stacking ensemble machine learning model to predict alpha-1 antitrypsin deficiency-associated liver disease clinical outcomes based on UK Biobank data | Scientific Reports
The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database | European Respiratory Society
Alpha1-Antitrypsin Deficiency | NEJM
Alpha-1 antitrypsin deficiency - Wikipedia
Alpha-1-antitrypsin deficiency | Asthma + Lung UK
Alpha-1 UK Support Group | Facebook
Helpful Information About Alpha-1 Antitrypsin-Associated Deficiency Liver Disease for Patients and Families | Dicerna Pharmaceuticals
Full article: The Effects of Inflammation on Alpha 1 Antitrypsin Levels in a National Screening Cohort
Trends of testing for and diagnosis of α1-antitrypsin deficiency in the UK: more testing is needed | European Respiratory Society
Alpha1-Antitrypsin Deficiency | NEJM
Suspecting and Testing for Alpha-1 Antitrypsin Deficiency—An Allergist's and/or Immunologist's Perspective - ScienceDirect
Treatment - Alpha-1 Foundation
Alpha -1 Antitrypsin Deficiency - St Vincent's Lung Health